Researchers have identified 23 blood proteins, including 15 novel markers, that could revolutionize how doctors predict and treat life-threatening blood clots in at-risk patients.
Most Recent Articles
Eliminating Hydrogel Waste: A Scalable Platform for Wearable Electrophysiology
A breakthrough in wearable tech has produced a self-adhesive, gel-free heart monitor that eliminates skin irritation while delivering hospital-grade ECG data for days at a time.
Phase III Evaluation of Asundexian in Non-Cardioembolic Stroke and TIA
A major Phase III trial reveals that the investigational drug asundexian reduces recurrent stroke risk by 26% without increasing the dangerous bleeding common in current treatments.
Identifying Active Disease via Epigenetic Gene Signatures in Osteosarcoma Patients
Blood test identifies a unique 136-gene signature in osteosarcoma patients, providing a promising less-invasive way to monitor bone cancer recurrence and metastatic spread.
Clinical Outcomes of Truncated Antimicrobial Therapy for Community-Acquired Pneumonia
New research shows that for stable pneumonia patients, a three-day antibiotic course is just as safe and effective as traditional five-day treatments, supporting better antimicrobial stewardship.